Key result
Early goal-directed therapy (EGDT) for severe sepsis and septic shock has been shown to modulate inflammation, decrease organ failure progression, and reduce mortality compared to standard care.
Why the study?
Does early goal-directed therapy (EGDT) improve outcomes in high-risk sepsis patients compared to standard care?
Does early goal-directed therapy (EGDT) improve outcomes in high-risk sepsis patients compared to standard care?
Early goal-directed therapy for severe sepsis and septic shock improves clinical outcomes and reduces mortality, supporting its implementation as a hospital-wide standard operating procedure.
EGDT may warrant protocol consideration in sepsis; extends prior reviews but leaves open need for updated RCTs.
Studies of acute myocardial infarction, trauma, and stroke have resulted in improved outcomes through earlier diagnosis and application of therapy at the most proximal stage of hospital presentation. Most critical therapies for these diseases are frequently instituted prior to admission to an ICU. This systems-based approach to the sepsis patient has been lacking. To change this paradigm, a trial comparing early goal-directed therapy (EGDT) versus standard care was performed using specific criteria for the early identification of high-risk sepsis patients and a consensus-derived protocol to reverse the hemodynamic perturbations of hypovolemia, vasoregulation, myocardial suppression, and increased metabolic demands. One decade later, EGDT has been shown to modulate inflammation, decrease the progression of organ failure, improve microcirculatory function, and decrease health resource consumption and mortality. A standard operating procedure beginning with EGDT for severe sepsis and septic shock is a hospital-wide initiative.
No takes yet. Share an insight, caveat, or question.
Rivers et al. (2011) conducted a review in severe sepsis and septic shock. early goal-directed therapy (EGDT) vs. standard care was evaluated on mortality, progression of organ failure, inflammation, microcirculatory function, and health resource consumption. Early goal-directed therapy (EGDT) for severe sepsis and septic shock has been shown to modulate inflammation, decrease organ failure progression, and reduce mortality compared to standard care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: